GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Shares Buyback Ratio %

Estrella Immunopharma (Estrella Immunopharma) Shares Buyback Ratio % : -3.79 (As of Jun. 08, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Estrella Immunopharma's current shares buyback ratio was -3.79%.


Estrella Immunopharma Shares Buyback Ratio % Historical Data

The historical data trend for Estrella Immunopharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Shares Buyback Ratio % Chart

Estrella Immunopharma Annual Data
Trend Jun21
Shares Buyback Ratio %
-

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -3.79

Estrella Immunopharma Shares Buyback Ratio % Calculation

Estrella Immunopharma's Shares Buyback Ratio for the fiscal year that ended in Jun. 2021 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: Jun. 2021 )) / Shares Outstanding (EOP) (A: . 20 )
=( - 35.201) /
=N/A%

Estrella Immunopharma's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Mar. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(35.2012 - 36.536) / 35.2012
=-3.79%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Estrella Immunopharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Estrella Immunopharma (Estrella Immunopharma) Business Description

Traded in Other Exchanges
N/A
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines